Peptide Record

GHK-Cu · Aging & appearance · graded 2026-07-30

Skin appearance & aging

This grade describes how much evidence exists for GHK-Cu against skin appearance & aging — not whether it works, and not whether it is safe. It is computed from the inputs below by a fixed rule with no editorial adjustment.

Why this grade

Not hidden behind a control — showing the work is the point
Score decomposition — every input and its contribution
ComponentPointsScale
Best study type
The strongest design that produced evidence for this outcome, not the average design.
+4Human RCT 5 · Human observational 4 · Animal 2 · Preclinical 1 · None 0
Largest human sample
Largest single human study, not a pooled total across studies.
+3n ≥ 200 → 3 · 50–199 → 2 · < 50 → 1 · no human study → 0
Independent replication
Distinct research groups at the best study tier above, resolved through author and institution records.
+1≥ 3 groups → 3 · 2 → 2 · 1 → 1 · 0 → 0
Directional consistency
Share of studies at the best study tier reporting effect in the same direction — the same studies the replication row counts, not every record on the pair.
Measured over 1 stated direction across 1 study at the best tier. A ratio over three readings and the same ratio over ninety are the same number and are not the same evidence.
0≥ 90% concordant → 3 · ≥ 70% → 2 · ≥ 50% → 1 · below → 0 · fewer than 3 readings → 0
Bias risk
A deduction, never a bonus. A flag is counted only where a record states one; silence is not a pass and is not a flag.
-1−1 per flag, floor −3: industry funding · no preregistration · no blinding
Total7Sum of the rows above, floored at 0.
What the bias row had to work with — how many of this pair’s records disclosed each field at all
FieldFlag statedStated the oppositeNot statedSilent
industry_funded
industry-funded deducts a point; declared non-commercial does not; silence does neither.
003100%
preregistered
not preregistered deducts a point; preregistered does not; silence does neither.
003100%
blinded
not blinded deducts a point; blinded does not; silence does neither.
10267%

Grade A additionally requires a total of at least 11 and replication of at least 2: a high score carried by one research group is not replicated evidence, however large the trial.

Doses administered in studies

Sourced figures, not a protocol

Studied doses — not yet collected

Dose, route and n are extracted from study full text, and full text is paywalled for most records in this corpus. No dose has been extracted for this pair yet. Read that as an extraction gap, not as evidence that the studies below administered nothing.

This is a gap in our collection, not a finding about studied doses. Read it as “we have not looked yet”, never as “there is nothing there”. How extraction works and where it fails

Cited sources

3 records · ordered by source hierarchy

These are the records the grade above was computed from — the same set, by the same rule, read from one definition shared with the grader. Records attributed to an alias for a materially different product are not among them; where this pair has any, they are listed separately below.

  • HUMAN-TRIAL1
  • ANIMAL1
  • PRECLINICAL1
SourceStudyDesignnBias flagsDate
HUMAN-TRIALIntradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.
PMID 29482481 · DOI 10.1080/14764172.2018.1439965 · matched on "Copper tripeptide-1"
human-observational1000not blinded2018-10-01
ANIMALEffect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts.
PMID 8836453 · matched on "Gly-His-Lys-Cu"
animalnone stated1995-11-01
PRECLINICALThe effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model.
PMID 11176716 · matched on "Copper tripeptide-1"
preclinicalnone stated2001-01-01

Rows are ordered by source hierarchy, so nothing below a regulatory filing appears above a human trial. A field marked uncertain is one where the extraction passes disagreed; it publishes as unknown rather than as a picked winner. A design reading “not determined” is a design nothing established, not a design of none. Explore the full corpus for GHK-Cu

Also collected, and not part of this grade

12 records · contributed nothing
SourceStudyDesignnBias flagsDate
HUMAN-TRIALEffects of topical copper tripeptide complex on CO2 laser-resurfaced skin.
PMID 16847171 · DOI 10.1001/archfaci.8.4.252 · matched on "GHK"
human-rct13none stated2006-07-01
ANIMALIn vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.
PMID 8227353 · DOI 10.1172/jci116842 · matched on "GHK"
animalnone stated1993-11-01
PRECLINICALAre We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?
PMID 39795193 · DOI 10.3390/molecules30010136 · matched on "GHK"
not determinednone stated2025-01-01
PRECLINICALSynergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests.
PMID 37062921 · DOI 10.1111/jocd.15763 · matched on "GHK"
preclinicalnone stated2023-09-01
PRECLINICALEffect of oligoarginine conjugation on the antiwrinkle activity and transdermal delivery of GHK peptide.
PMID 31788907 · DOI 10.1002/psc.3234 · matched on "GHK"
preclinicalnone stated2020-02-01
PRECLINICALSelected Biomarkers Revealed Potential Skin Toxicity Caused by Certain Copper Compounds.
PMID 27892491 · DOI 10.1038/srep37664 · matched on "GHK"
preclinicalnone stated2016-11-28
PRECLINICALMicroneedle-Mediated Delivery of Copper Peptide Through Skin.
PMID 25690343 · DOI 10.1007/s11095-015-1652-z · matched on "GHK"
not determinednone stated2015-08-01
PRECLINICALEffect of GLY-HIS-LYS and its copper complex on TGF-beta secretion in normal human dermal fibroblasts.
PMID 25745767 · matched on "GHK"
preclinicalnone stated2014-11-01
PRECLINICALThe tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures.
PMID 11045606 · DOI 10.1016/s0024-3205(00)00803-1 · matched on "GHK"
not determinednone stated2000-09-22
PRECLINICALEffects of the tripeptide glycyl-L-histidyl-L-lysine copper complex on osteoblastic cell spreading, attachment and phenotype.
PMID 8747089 · matched on "GHK"
preclinicalnone stated1995-12-01
PRECLINICALStimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
PMID 1522753 · DOI 10.1016/0024-3205(92)90504-i · matched on "GHK"
preclinicalnone stated1992-01-01
PRECLINICALStimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
PMID 3169264 · DOI 10.1016/0014-5793(88)80509-x · matched on "GHK"
preclinicalnone stated1988-10-10